Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Dick, Andrew; Tugal-Tutkun, Nuriye; Foster, Stephen; ZIERHUT, Manfred; LIEW, S.; BEZLYAK, Vladimir; Androudi, Sofia

doi:10.1016/j.ophtha.2012.09.040

Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Atıf İçin Kopyala

Dick A. D., Tugal-Tutkun I., Foster S., ZIERHUT M., LIEW S. H. M., BEZLYAK V., ...Daha Fazla

OPHTHALMOLOGY, cilt.120, sa.4, ss.777-787, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 120 Sayı: 4
Basım Tarihi: 2013
Doi Numarası: 10.1016/j.ophtha.2012.09.040
Dergi Adı: OPHTHALMOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.777-787
İstanbul Üniversitesi Adresli: Evet

Özet

Purpose: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A blockade, in patients with noninfectious uveitis.